These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
240 related items for PubMed ID: 21402997
21. Advanced unilateral retinoblastoma: a case of sparing enucleation treatment failure. Valente P, De Ioris MA, Romanzo A, Cozza R, Natali G, Buzzonetti L. Can J Ophthalmol; 2016 Apr; 51(2):e40-3. PubMed ID: 27085272 [No Abstract] [Full Text] [Related]
22. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors. Shields CL, Mashayekhi A, Cater J, Shelil A, Ness S, Meadows AT, Shields JA. Arch Ophthalmol; 2005 Jun; 123(6):765-73. PubMed ID: 15955977 [Abstract] [Full Text] [Related]
23. Lack of vincristine infiltrates in patients with retinoblastoma receiving chemotherapy by peripheral intravenous lines. DiDomenico C, Clerico D, Leahey A. Pediatr Blood Cancer; 2015 Oct; 62(10):1859-61. PubMed ID: 25929686 [Abstract] [Full Text] [Related]
24. Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors. Shields CL, Mashayekhi A, Cater J, Shelil A, Meadows AT, Shields JA. Am J Ophthalmol; 2004 Sep; 138(3):329-37. PubMed ID: 15364213 [Abstract] [Full Text] [Related]
25. Retinoblastoma CSF metastasis cured by multimodality chemotherapy without radiation. Dimaras H, Héon E, Budning A, Doyle JJ, Halliday W, Gallie BL, Chan HS. Ophthalmic Genet; 2009 Sep; 30(3):121-6. PubMed ID: 19941416 [Abstract] [Full Text] [Related]
33. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients. Shields CL, Shelil A, Cater J, Meadows AT, Shields JA. Arch Ophthalmol; 2003 Nov; 121(11):1571-6. PubMed ID: 14609913 [Abstract] [Full Text] [Related]
34. Practical approach to management of retinoblastoma. Shields CL, Mashayekhi A, Demirci H, Meadows AT, Shields JA. Arch Ophthalmol; 2004 May; 122(5):729-35. PubMed ID: 15136321 [Abstract] [Full Text] [Related]
35. Intra-arterial chemotherapy combined with VEC intravenous chemotherapy in the treatment of advanced retinoblastoma. Xu K, Liu J, Zhang C. J BUON; 2020 May; 25(2):1199-1205. PubMed ID: 32521926 [Abstract] [Full Text] [Related]
36. Minimal disseminated disease evaluation and outcome in trilateral retinoblastoma. Torbidoni AV, Sampor C, Laurent VE, Aschero R, Iyer S, Rossi J, Alderete D, Alonso DF, Szijan I, Chantada GL. Br J Ophthalmol; 2018 Nov; 102(11):1597-1601. PubMed ID: 30150278 [Abstract] [Full Text] [Related]
38. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors. Shields CL, Mashayekhi A, Cater J, Shelil A, Meadows AT, Shields JA. Trans Am Ophthalmol Soc; 2004 Apr; 102():35-44; discussion 44-5. PubMed ID: 15747743 [Abstract] [Full Text] [Related]
39. Successful therapy for trilateral retinoblastoma. Nelson SC, Friedman HS, Oakes WJ, Halperin EC, Tien R, Fuller GN, Hockenberger B, Scroggs MW, Moncino M, Kurtzberg J. Am J Ophthalmol; 1992 Jul 15; 114(1):23-9. PubMed ID: 1621782 [Abstract] [Full Text] [Related]
40. Resolution of iris neovascularization following chemoreduction of advanced retinoblastoma. Shields CL, Sun H, Manquez ME, Leahey A, Meadows AT, Shields JA. Arch Ophthalmol; 2006 Aug 15; 124(8):1196-7. PubMed ID: 16908826 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]